These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2526262)

  • 21. [Disorders of coagulation in gynecology and obstetrics. 1. Mechanisms of coagulation and their exploration].
    Hendeles SM; Vekemans M
    J Gynecol Obstet Biol Reprod (Paris); 1973; 2(8):1073-87. PubMed ID: 4620225
    [No Abstract]   [Full Text] [Related]  

  • 22. [Attempt at explanation of the mechanism of labor. I. Coagulation system and fibrinolysis during physiological labor].
    Konopka P; Gaszynski W; Nowak J
    Rev Fr Gynecol Obstet; 1973 Jan; 68(1):1-6. PubMed ID: 4687577
    [No Abstract]   [Full Text] [Related]  

  • 23. [Consumption coagulopathy--intravascular coagulation syndrome].
    Matsuoka M; Watanabe T
    Naika; 1970 Dec; 26(6):1043-54. PubMed ID: 4922782
    [No Abstract]   [Full Text] [Related]  

  • 24. Tissue factor and tissue factor pathway inhibitor.
    Price GC; Thompson SA; Kam PC
    Anaesthesia; 2004 May; 59(5):483-92. PubMed ID: 15096242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Studies on thromboplastin activity, fibrinolysis and uptake of radioactive iodine-labeled fibrinogen in various experimental tumors].
    Hilgard P; Heyes H; Sigmund E; Hiemeyer V
    Fortschr Geb Rontgenstr Nuklearmed; 1970 Jul; 113(1):96-100. PubMed ID: 5534016
    [No Abstract]   [Full Text] [Related]  

  • 26. Characterization of mouse thrombin-activatable fibrinolysis inhibitor.
    Marx PF; Wagenaar GT; Reijerkerk A; Tiekstra MJ; van Rossum AG; Gebbink MF; Meijers JC
    Thromb Haemost; 2000 Feb; 83(2):297-303. PubMed ID: 10739389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue factor pathway inhibitor revisited.
    Hjort PF; Sandset PM; Abildgaard U; Rao LV; Mast A; Ott I; Bajaj SP
    J Thromb Haemost; 2004 Dec; 2(12):2241-9. PubMed ID: 15613032
    [No Abstract]   [Full Text] [Related]  

  • 28. Carbon monoxide-releasing molecule-2 enhances coagulation and diminishes fibrinolytic vulnerability in diluted plasma in vitro.
    Nielsen VG; Green P; Green M; Martin-Ross A; Khan ES; Kirklin JK; George JF
    J Trauma; 2011 Apr; 70(4):939-47. PubMed ID: 20693919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Coagulation and fibrinolysis observed in the placenta].
    Soma H; Koyanagi K; Sashida T; Nagata K; Yoshida M
    Nihon Sanka Fujinka Gakkai Zasshi; 1970 May; 22(5):515-20. PubMed ID: 5464785
    [No Abstract]   [Full Text] [Related]  

  • 30. A global assay of haemostasis which uses recombinant tissue factor and tissue-type plasminogen activator to measure the rate of fibrin formation and fibrin degradation in plasma.
    He S; Zhu K; Skeppholm M; Vedin J; Svensson J; Egberg N; Blombäck M; Wallen H
    Thromb Haemost; 2007 Oct; 98(4):871-82. PubMed ID: 17938814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mechanism of the occurrence of blood noncoagulability on the entrance into the blood stream of substances with thromboplastin activity].
    Oĭvin IA; Baluda VP
    Probl Gematol Pereliv Krovi; 1972 Apr; 17(4):23-8. PubMed ID: 4680850
    [No Abstract]   [Full Text] [Related]  

  • 32. The changing faces of tissue factor biology. A personal tribute to the understanding of the "extrinsic coagulation activation".
    Wiiger MT; Prydz H
    Thromb Haemost; 2007 Jul; 98(1):38-42. PubMed ID: 17597988
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of protein C inhibitor and tissue factor in fertilization.
    Fernández JA; Heeb MJ
    Semin Thromb Hemost; 2007 Feb; 33(1):13-20. PubMed ID: 17253185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Changes in the blood coagulation and fibrinolysis system in the course of normal pregnancy].
    Justus B; Siegert G; Tiebel O
    Zentralbl Gynakol; 1992; 114(4):165-70. PubMed ID: 1621453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Thromboplastic and fibrinolytic activity of the tissues of pregnant uterus and the elements of fertilized ovum].
    Vdovina GF; Skipetrov VP; Azbukina LN
    Vopr Okhr Materin Det; 1975 Jun; 20(6):75-9. PubMed ID: 1136329
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies on the tissue thromboplastin during the coagulation-fibrinolytic process--ultrastructural changes.
    Hasegawa H; Nagata H; Murao M
    Thromb Haemost; 1977 Jun; 37(3):541-8. PubMed ID: 578034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Syndromes of intravascular coagulation.
    Rodríguez-Erdmann F
    Surg Annu; 1977; 9():1-28. PubMed ID: 329449
    [No Abstract]   [Full Text] [Related]  

  • 38. [Mechanism of changes in blood clotting and fibrinolysis under the influence of a constant electric current].
    Mishchenko VP; Mishchenko VI
    Biofizika; 1977; 22(3):489-92. PubMed ID: 889909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intravascular blood coagulation and its role in malignant neoplasms].
    Pavlovskiĭ DP
    Vopr Onkol; 1981; 27(7):96-103. PubMed ID: 7023043
    [No Abstract]   [Full Text] [Related]  

  • 40. [Phospholipids and various blood coagulation problems in experimental thrombosis].
    Karagezian KG; Ovakimian SS; Mirza-Avakian GL
    Vopr Med Khim; 1970; 16(5):503-8. PubMed ID: 5523766
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.